Clinical comparison · Weight loss
Semaglutide vs AOD-9604
Semaglutide is the anchor GLP-1. AOD-9604 is a fat-mobilizing hGH fragment used as an adjunct, not a replacement.
Attribute
Semaglutide
AOD-9604
Mechanism
GLP-1 receptor agonist. Delays gastric emptying, boosts satiety, augments insulin secretion.
Modified fragment of hGH (176–191). Stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 or blood glucose.
Standard dosing
0.25 mg weekly, titrated q4 weeks to a 1.7–2.4 mg maintenance dose.
300 mcg SC daily, typically 5-on/2-off.
Indications
- Medical weight loss
- Metabolic syndrome adjunct
- Type 2 diabetes (branded)
- Body composition
- Stubborn adipose reduction
- Adjunct to GLP-1
Strengths
- Long clinical history
- Simpler side-effect profile at low doses
- Lower cost per week
- No IGF-1 or glucose impact
- Clean side-effect profile
Cautions
- Slower weight-loss curve than tirzepatide
- GI side effects during titration
- MTC / MEN2 contraindication
- Modest standalone effect
- Best as adjunct, not monotherapy
Choose AOD-9604 when
Adjunct to accelerate stubborn adipose reduction on top of a GLP-1 or GH protocol.
Wholesale AOD-9604 →FAQs
- Can AOD-9604 replace semaglutide?
- No. Effect size is much smaller. Use it as an adjunct, not a standalone.
- Can they be stacked?
- Yes. AOD-9604 300 mcg SC daily alongside a standard semaglutide titration is a common combination.